دارو جابرابن حیان
دجابر | Stocks - Tehran Stock Exchange (TSE)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
Authorized
Last Price: 57,940 3.00
Close Price: 57,940
Income Statement
AGM
Interim
2026/04/19 Fiscal Year 2025/12/2112 Month | 2025/02/18 Fiscal Year 2024/12/2012 Month | 2024/03/16 Fiscal Year 2023/12/2112 Month | ||
|---|---|---|---|---|
Revenue from Services & Sales | 15.927 Trillion | 12.603 Trillion | 10.635 Trillion | |
Total Revenues | 15.927 Trillion | 12.603 Trillion | 10.635 Trillion | |
Cost of Goods Sold | 11.155 Trillion | 10.06 Trillion | 7.758 Trillion | |
Gross Profit | 4.771 Trillion | 2.543 Trillion | 2.877 Trillion | |
General & Administrative Expenses | 1.61 Trillion | 1.268 Trillion | 824.782 Billion | |
Net Operating Income & Expenses | -1.223 Trillion | -379.135 Billion | -168.001 Billion | |
Operating Profit (Loss) | 1.939 Trillion | 896.278 Billion | 1.884 Trillion | |
Profit Before Tax | 1.451 Trillion | 8.277 Trillion | 1.809 Trillion | |
Tax | 28.366 Billion | - | 190.898 Billion | |
Net Profit (Loss) After Tax | 1.423 Trillion | 8.277 Trillion | 1.618 Trillion | |
Retained Earnings at Beginning of Period | 11.311 Trillion | 4.169 Trillion | 5.272 Trillion | |
Approved Dividends — Prior Year AGM | -3.515 Trillion | -1.134 Trillion | -2.722 Trillion | |
Allocable Profit | 9.218 Trillion | 11.311 Trillion | 4.169 Trillion | |
Approved Dividends — Current Year | 2.722 Trillion | 3.515 Trillion | 1.134 Trillion | |
Retained Earnings at End of Period | 6.497 Trillion | 7.796 Trillion | 3.035 Trillion |